157 related articles for article (PubMed ID: 21714932)
21. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
J Am Geriatr Soc; 2004 Dec; 52(12):1981-7. PubMed ID: 15571531
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
Raskin P; Ganda OP; Schwartz S; Willard D; Rosenstock J; Lodewick PA; Cressman MD; Phillipson B; Weiner B; McGovern ME
Am J Med; 1995 Oct; 99(4):362-9. PubMed ID: 7573090
[TBL] [Abstract][Full Text] [Related]
23. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
24. Preventive effect of pravastatin on the development of hypertension in patients with hypercholesterolemia: A post-hoc analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
Otsuka T; Mizuno K; Shinozaki T; Kachi Y; Nakamura H
J Clin Lipidol; 2017; 11(4):998-1006. PubMed ID: 28655522
[TBL] [Abstract][Full Text] [Related]
25. Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT).
Koizumi J; Shimizu M; Miyamoto S; Origasa H; Mabuchi H
J Atheroscler Thromb; 2002; 9(5):251-9. PubMed ID: 12409635
[TBL] [Abstract][Full Text] [Related]
26. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.
Ikeda F; Doi Y; Ninomiya T; Hirakawa Y; Mukai N; Hata J; Shikata K; Yoshida D; Matsumoto T; Kitazono T; Kiyohara Y
Cardiovasc Diabetol; 2013 Nov; 12():164. PubMed ID: 24195452
[TBL] [Abstract][Full Text] [Related]
27. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
Nishimura R; Sone H; Nakagami T; Tajima N
Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
[TBL] [Abstract][Full Text] [Related]
28. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study.
Izawa A; Kashima Y; Miura T; Ebisawa S; Kitabayashi H; Yamamoto H; Sakurai S; Kagoshima M; Tomita T; Miyashita Y; Koyama J; Ikeda U;
Circ J; 2015; 79(1):161-8. PubMed ID: 25392071
[TBL] [Abstract][Full Text] [Related]
29. Pravastatin use and risk of coronary events and cerebral infarction in japanese men with moderate hypercholesterolemia: the Kyushu Lipid Intervention Study.
J Atheroscler Thromb; 2000; 7(2):110-21. PubMed ID: 11426582
[TBL] [Abstract][Full Text] [Related]
30. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
[TBL] [Abstract][Full Text] [Related]
31. Pravastatin and cardiovascular risk in moderate chronic kidney disease.
Nakamura H; Mizuno K; Ohashi Y; Yoshida T; Hirao K; Uchida Y;
Atherosclerosis; 2009 Oct; 206(2):512-7. PubMed ID: 19423108
[TBL] [Abstract][Full Text] [Related]
32. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
Sawayama Y; Shimizu C; Maeda N; Tatsukawa M; Kinukawa N; Koyanagi S; Kashiwagi S; Hayashi J
J Am Coll Cardiol; 2002 Feb; 39(4):610-6. PubMed ID: 11849859
[TBL] [Abstract][Full Text] [Related]
33. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
[TBL] [Abstract][Full Text] [Related]
34. Risk reductions for cardiovascular disease with pravastatin treatment by dyslipidemia phenotype: a post hoc analysis of the MEGA Study.
Nishiwaki M; Ikewaki K; Ayaori M; Mizuno K; Ohashi Y; Ohsuzu F; Ishikawa T; Nakamura H;
J Cardiol; 2013 Mar; 61(3):196-200. PubMed ID: 23265677
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
[TBL] [Abstract][Full Text] [Related]
36. Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Baimbridge C; Davis BR; Barzilay J; Basile JN; Henriquez MA; Huml A; Kopyt N; Louis GT; Pressel SL; Rosendorff C; Sastrasinh S; Stanford C;
Am J Kidney Dis; 2008 Sep; 52(3):412-24. PubMed ID: 18676075
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group.
Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M
Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495
[TBL] [Abstract][Full Text] [Related]
39. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
Al-Shamsi S; Regmi D; Govender RD
BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
[TBL] [Abstract][Full Text] [Related]
40. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
Daida H; Takayama T; Hiro T; Yamagishi M; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
Cardiovasc Diabetol; 2012 Jul; 11():87. PubMed ID: 22831708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
